Market Tracker

09/04 6:01pm ET

SPDR® S&P Biotech ETF (XBI)

During the Trading Day
218.67 +0.53 / +0.24%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
218.80 +0.13 / +0.06%
 
Volume: 600.00

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month-14.57% 3 years+35.88%
3 months-9.54% 5 years+32.04%
1 year+36.48% Since inception+17.14%
Data through 09/04/2015

Quote Details

Previous close$218.14
Open day’s range214.03 – 222.03
Net asset value (NAV)218.07 (09/03/2015)
Daily volume1,634,341
Average volume (3 months)1,516,762
Data as of 3:59pm ET, 09/04/2015

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+32.04%+26.72%
Expense Gross exp ratio0.35%0.46%
Risk 5 year sharpe ratio1.281.60
Net assets$2.6B$1.9B
Average market cap$2.1B$38.7B
Average P/E--26.0
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ANAC Anacor Pharmaceuticals Inc2.04%
EXEL Exelixis Inc1.81%
KYTH KYTHERA Biopharmaceuticals Inc1.48%
DVAX Dynavax Technologies Corp1.47%
SRPT Sarepta Therapeutics Inc1.40%
PRTA Prothena Corporation PLC1.38%
RDUS Radius Health Inc1.38%
RARE Ultragenyx Pharmaceutical Inc1.37%
HRTX Heron Therapeutics Inc1.36%
NVAX Novavax Inc1.31%